SCHEMBL31196202

SCHEMBL31196202

N#Cc1cc(F)cc([C@@H]2CCON2C(=O)[C@H]2CCC[C@H](COc3cc(C(N)=O)ncn3)CC2)c1

nearest known ligand 0.57

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 10/20 0.57
PARP15 Q460N3 1/20 0.31
PARP10 Q53GL7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31196244 1.00 RIPK1 (0.57) RIPK1PARP15PARP10
SCHEMBL31196115 1.00 RIPK1 (0.57) RIPK1PARP15PARP10
SCHEMBL31196232 0.93 RIPK1 (0.51) RIPK1PARP15PARP10
SCHEMBL31196165 0.93 RIPK1 (0.51) RIPK1PARP15PARP10
SCHEMBL31196131 0.92 RIPK1 (0.56) RIPK1
SCHEMBL31196374 0.92 RIPK1 (0.56) RIPK1
SCHEMBL31196108 0.90 RIPK1 (0.54) RIPK1PARP15PARP10
SCHEMBL31196507 0.90 RIPK1 (0.54) RIPK1PARP15PARP10
SCHEMBL31196372 0.85 RIPK1 (0.51) RIPK1
SCHEMBL31196298 0.85 RIPK1 (0.51) RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4709716-A1 ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF GENZYME CORPORATION (US) 2026-03-18 EP claimed
WO-2024233554-A1 ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF GENZYME CORPORATION (US) 2024-11-14 WO claimed
EP-4709716-A1 ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF GENZYME CORPORATION (US) 2026-03-18 EP disclosed
WO-2024233554-A1 ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF GENZYME CORPORATION (US) 2024-11-14 WO disclosed